Vitatron. The Pace Makers
Vitatron – based in Europe – is the only medical device company that specializes exclusively
in pacemakers. Since 1962, Vitatron pacemakers have helped restore more than 600,000
people in more than 60 countries to a full life. We strive to achieve perfection in everything
we do. This results in unique patient-focused therapies, as well as highly cost-effective
E60 DR Dual Chamber Specifications Head Office: Vitatron Holding BV Endepolsdomein 5, Sales Offices:
Vitatron is further represented by dealers throughout
the world. All specifications subject to change
E60DR Specifications Model E60A1 Mechanical Rate Response Pacing Diagnostics Follow-up and Troubleshooting
60, 65, 70…95…175, 180 ppm Cardiac Dashboard II Size (HxWxD mm) Highlights significant events, pacing summary, threshold and impedance
1, 2, 3, 4, 5
1, 2, 3, 4, 5 Connector
Low, Medium Low, Medium High, High Radiopaque ID
15 s, 30 s, 60 s
Pacing summary and access to rate histogram
2.5 min, 5 min, 10 min, Exercise
Atrial and ventricular lead impedance trends
50, 55, 60.80.175 ppm
55, 60, 65.120.180 ppm Histogram reports
-10, -20, -30.-40.-300 ms Longevity Additional pacing features Atrial and ventricular episodes
Atrial and ventricular high rate episodes
Bradycardia Pacing Magnet mode operation Programmable parameters Atrial Tachyarrhythmia Therapies and Interventions DDDR, DDD, DDIR, DDI, DVIR, DVI, Mode Switch
120, 125.175.200 ppm No Delay, 10, 20.60 sec Clinician selected diagnostics
30, 35, 40…60…170, 175 ppm Conducted AF Responsec
Regularize V-V during AT/AF On, Off
80, 90, 95…130…180 ppm
80, 85, 90.110.130 Recommended Replacement Time (RRT/ERI)
80, 90, 95…130…180 ppm Patient Data Management
Replacement message on programmer (Cardiac Dashboard II)
A and RV Pulse Amplitudeb 0.5, 0.75, 1.0…3.5…4, 4.5, 5, 5.5, Non-Competitive Atrial Pacing On, Off Patient data stored in device
0.12, 0.15, 0.21, 0.27, 0.34, 0.4, Automatic Pacing, Sensing, and Lead Monitor Implant Detection and Initialization
0.18, 0.25, 0.35, 0.5, 0.7, 1, 1.4, 2,
At the completion of the 30-minute Implant Detection period,
References
Rate Profile Optimization is enabled; the appropriate pacing
Data management
a The atrial and ventricular rate limit is 200 min-1 (± 20 min-1).
1, 1.4, 2, 2.8, 4, 5.6, 8, 11.2 mV
and sensing polarities are automatically selected by the device;
Automatic printing of initial interrogation report
b Tolerance for amplitudes from 0.5 V through 6.0 V is ± 10% and for
Ventricular Output Management is enabled and Amplitude and Pulse
7.5 V is -20/+0%. Tolerances are based on 37°C and a 500 Ω load.
Width become adaptive. Reduced VP™+ is enabled 60 minutes
Save-to-Disk capacity for electronic file management
Amplitude is determined 200 µs after the leading edge of the pace.
30, 40, 50 .150.350 ms
after Implant Detection is complete.
c Conducted AF response is functional during Mode Switch episodes,
30, 40, 50 .120.350 ms Auto, Varied, 150, 160, 170 .500 ms
* DDDR or DDD, 60ppm, 100% pacing, ventricular 2.0 V,† atrial,
150, 160, 170.250.500 ms
1.5 V, † 0.4 ms pulse width, 1000 Ω pacing impedance
130, 140, 150.180.350 ms
180, 190, 200…250…500 ms
† Ventricular output management minimum adapted values at
130, 140, 150…180…350 ms
1000, 2000, 3000, 4000 Ω
Ventricular Refractory Period 150, 160, 170…230…500 ms
2, 3, 4 … 8 … 16
Nominal values indicated in bold
20, 28, 36,44 ms Ventricular Output Management Ventricular Output Therapies to promote intrinsic activation
Off, Monitor Only, Adaptive
1.5x, 2x, 2.5x, 3x, 4x (times)
10, 20, 30.170.250 ms
0.5, 0.75…2…3.5 V
3, 5, 10, 15, 20 ppm
5, 10, 20, 30 min Day at rest; Day at…; 7 days at
30, 35, 40…50…90 ppm
Off, 7, 14, 21…84, 112, 140, 168… 22:00…23:45
Unipolar, Bipolar, Adaptive 8:00…23:45
Single Chamber Hysteresis Off, 40, 50, 60 ppm
FOGLIO ILLUSTRATIVO: INFORMAZIONI PER L’UTILIZZATORE DUODOPA 20 mg/ml + 5 mg/ml gel intestinale Levodopa e carbidopa monoidrato Legga attentamente questo foglio prima di usare il medicinale. - Conservi questo foglio. Potrebbe aver bisogno di leggerlo di nuovo. Se ha qualsiasi dubbio, si rivolga al medico o al farmacista. Questo medicinale è stato prescritto per lei personalme
ANTIBIOTIC PRESCRIBING GUIDELINES FOR THE STROKE WARDS (BERMAN 1, BEESTON, NEWALL AND SEACOLE) Annette Clarkson Senior pharmacist antimicrobials and infection control Dr Vivienne Weston Consultant microbiologist Date on which guideline must be reviewed (this should be one to Explicit definition of patient group to which it applies (e.g. inclusion Applies to: Adult stroke patients on strok